Clinical Trial Update: Pegylated Interferon, Ribavirin, Telaprevir in Hepatitis C Virus Infection in Orthotopic Liver Transplant Recipients [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating pegylated interferon, ribavirin, and telaprevir for Hepatitis C in liver transplant recipients; the study was terminated with …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis C

Drugs mentioned

• Copegus (ribavirin)
• Pegasys (pegylated interferon alfa-2a)
• Telaprevir (telaprevir)

Snippet

Sponsor: University of Chicago | Conditions: Hepatitis C | Phase 4 | Status: TERMINATED | Results posted: 2015-01-12